1
1
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
T1458 |
Epalrestat
ONO2235,依帕斯他,依帕司他 |
Reductase | Endocrinology/Hormones; Metabolism |
Epalrestat (ONO2235) 是醛糖还原酶抑制剂,在长期治疗中具有良好的耐受性。 它可以有效改善糖尿病神经病变的相关症状并延缓疾病的进展,特别是在微血管病变有限且血糖控制良好的患者中。 |
Cat. No. | Product Name | Target | Signaling Pathways |
---|---|---|---|
TN3760 |
Danshenol A
|
Reductase | Endocrinology/Hormones; Metabolism |
Danshenol A has strong aldose reductase (AR) inhibitory activity, has IC50 of 0.10 microM which is comparable to that of epalrestat in clinical use. Danshenol A also has antitumor activity in T-24, QGY, K562, Me180 and BIU87 cell lines, shows inhibited growth of K562 (IC50 = 0.53 μg/mL), T-24 (IC50 = 7.94 μg/mL), QGY (IC50 = 4.65 μg/mL) and Me180 (IC50 = 6.89 μg/mL) cell lines. |